SCHEDULE 13G: Vivien Rakib Discloses 17.5% Stake in BioHarvest Sciences Inc.
Schedule 13G
Vivien Rakib has filed a Schedule 13G, reporting beneficial ownership of 17.5% of BioHarvest Sciences Inc.'s common shares as of August 13, 2024.
Summary
- Vivien Rakib, a citizen of Israel, filed a Schedule 13G with the SEC.
- The filing reports beneficial ownership of common shares of BIOHARVEST SCIENCES INC., with principal executive offices in Vancouver, British Columbia, Canada.
- As of August 13, 2024, Vivien Rakib beneficially owned 3,033,190 common shares of BioHarvest Sciences Inc.
- This ownership represents 17.5% of the total class of securities.
- Vivien Rakib holds sole voting power and sole dispositive power over all 3,033,190 shares.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain performance metrics or forward-looking statements that would inherently indicate a positive or negative sentiment. The large stake by a director could be seen as a positive signal of confidence, but the filing itself is neutral in tone.
Positives
- The disclosure of a significant individual stake (17.5%) by Vivien Rakib, identified as a Director, could signal strong confidence in the company's future prospects from an insider.
Future Outlook
NA
Management Comments
- "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."
Industry Context
This filing is a standard beneficial ownership disclosure and does not provide specific details to analyze broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: The disclosure of a significant individual stake (17.5%) by a director provides transparency regarding the ownership structure and may influence investor perception of insider confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 08/13/2024 | Date of event which requires filing of this statement (beneficial ownership threshold met). |
| 02/11/2025 | Date of signature for the Schedule 13G filing. |
Keywords
BioHarvest Sciences Inc., Vivien Rakib, Schedule 13G, beneficial ownership, common shares, SEC filing, shareholder, stake, 09076J207
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.